3
|
Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F. Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. PLoS One 2013; 8:e60127. [PMID: 23613718 PMCID: PMC3629047 DOI: 10.1371/journal.pone.0060127] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2012] [Accepted: 02/22/2013] [Indexed: 12/16/2022] Open
Abstract
The CoPanFlu-France cohort of households was set up in 2009 to study the risk factors for infection by the pandemic influenza virus (H1N1pdm) in the French general population. The authors developed an integrative data-driven approach to identify individual, collective and environmental factors associated with the post-seasonal serological H1N1pdm geometric mean titer, and derived a nested case-control analysis to identify risk factors for infection during the first season. This analysis included 1377 subjects (601 households). The GMT for the general population was 47.1 (95% confidence interval (CI): 45.1, 49.2). According to a multivariable analysis, pandemic vaccination, seasonal vaccination in 2009, recent history of influenza-like illness, asthma, chronic obstructive pulmonary disease, social contacts at school and use of public transports by the local population were associated with a higher GMT, whereas history of smoking was associated with a lower GMT. Additionally, young age at inclusion and risk perception of exposure to the virus at work were identified as possible risk factors, whereas presence of an air humidifier in the living room was a possible protective factor. These findings will be interpreted in light of the longitudinal analyses of this ongoing cohort.
Collapse
Affiliation(s)
- Nathanael Lapidus
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
McCaw JM, Howard PF, Richmond PC, Nissen M, Sloots T, Lambert SB, Lai M, Greenberg M, Nolan T, McVernon J. Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults. BMC Infect Dis 2012; 12:345. [PMID: 23231698 PMCID: PMC3538067 DOI: 10.1186/1471-2334-12-345] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Accepted: 12/06/2012] [Indexed: 02/04/2023] Open
Abstract
Background Household transmission of influenza-like illness (ILI) may vary with viral and demographic characteristics. We examined the effect of these factors in a population-based sample of adults with ILI. Methods We conducted a prospective cohort study in community-dwelling Australian adults nested within an influenza vaccine effectiveness trial. On presentation with ILI, participants were swabbed for a range of respiratory viruses and asked to return a questionnaire collecting details of household members with or without similar symptoms. We used logistic and Poisson regression to assess the key characteristics of household transmission. Results 258 participants from multi-occupancy households experienced 279 ILI episodes and returned a questionnaire. Of these, 183 were the primary case in the household allowing assessment of factors associated with transmission. Transmission was significantly associated in univariate analyses with female sex (27% vs. 13%, risk ratio (RR) = 2.13 (1.08, 4.21)) and the presence of a child in the house (33% vs. 17%, RR = 1.90 (1.11, 3.26)). The secondary household attack proportion (SHAP) was 0.14, higher if influenza was isolated (RR = 2.1 (1.0, 4.5)). Vaccinated participants who nonetheless became infected with influenza had a higher SHAP (Incidence RR = 5.24 (2.17, 12.6)). Conclusions The increased SHAP in households of vaccinated participants who nonetheless had confirmed influenza infection supports the hypothesis that in years of vaccine mismatch, not only is influenza vaccine less protective for the vaccine recipient, but that the population’s immunity is also lower.
Collapse
Affiliation(s)
- James M McCaw
- Murdoch Children's Research Institute & Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria, 3010, Australia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Glatman-Freedman A, Portelli I, Jacobs SK, Mathew JI, Slutzman JE, Goldfrank LR, Smith SW. Attack rates assessment of the 2009 pandemic H1N1 influenza A in children and their contacts: a systematic review and meta-analysis. PLoS One 2012; 7:e50228. [PMID: 23284603 PMCID: PMC3523802 DOI: 10.1371/journal.pone.0050228] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2012] [Accepted: 10/18/2012] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND The recent H1N1 influenza A pandemic was marked by multiple reports of illness and hospitalization in children, suggesting that children may have played a major role in the propagation of the virus. A comprehensive detailed analysis of the attack rates among children as compared with their contacts in various settings is of great importance for understanding their unique role in influenza pandemics. METHODOLOGY/PRINCIPAL FINDINGS We searched MEDLINE (PubMed) and Embase for published studies reporting outbreak investigations with direct measurements of attack rates of the 2009 pandemic H1N1 influenza A among children, and quantified how these compare with those of their contacts. We identified 50 articles suitable for review, which reported school, household, travel and social events. The selected reports and our meta-analysis indicated that children had significantly higher attack rates as compared to adults, and that this phenomenon was observed for both virologically confirmed and clinical cases, in various settings and locations around the world. The review also provided insight into some characteristics of transmission between children and their contacts in the various settings. CONCLUSION/SIGNIFICANCE The consistently higher attack rates of the 2009 pandemic H1N1 influenza A among children, as compared to adults, as well as the magnitude of the difference is important for understanding the contribution of children to disease burden, for implementation of mitigation strategies directed towards children, as well as more precise mathematical modeling and simulation of future influenza pandemics.
Collapse
Affiliation(s)
- Aharona Glatman-Freedman
- Department of Family and Community Medicine, New York Medical College, Valhalla, New York, United States of America.
| | | | | | | | | | | | | |
Collapse
|
7
|
Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F. Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort. BMC Public Health 2012; 12:417. [PMID: 22676272 PMCID: PMC3461458 DOI: 10.1186/1471-2458-12-417] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2012] [Accepted: 06/07/2012] [Indexed: 11/24/2022] Open
Abstract
BACKGROUND The risk of influenza infection depends on biological characteristics, individual or collective behaviors and the environmental context. The Cohorts for Pandemic Influenza (CoPanFlu) France study was set up in 2009 after the identification of the novel swine-origin A/H1N1 pandemic influenza virus. This cohort of 601 households (1450 subjects) representative for the general population aims at using an integrative approach to study the risk and characteristics of influenza infection as a complex combination of data collected from questionnaires regarding sociodemographic, medical, behavioral characteristics of subjects and indoor environment, using biological samples or environmental databases. METHODS/DESIGN Households were included between December 2009 and July 2010. The design of this study relies on systematic follow-up visits between influenza seasons and additional visits during influenza seasons, when an influenza-like illness is detected in a household via an active surveillance system. During systematic visits, a nurse collects individual and environmental data on questionnaires and obtains blood samples from all members of the household. When an influenza-like-illness is detected, a nurse visits the household three times during the 12 following days, and collects data on questionnaires regarding exposure and symptoms, and biological samples (including nasal swabs) from all subjects in the household. The end of the follow-up period is expected in fall 2012. DISCUSSION The large amount of data collected throughout the follow-up will permit a multidisciplinary study of influenza infections. Additional data is being collected and analyzed in this ongoing cohort. The longitudinal analysis of these households will permit integrative analyses of complex phenomena such as individual, collective and environmental risk factors of infection, routes of transmission, or determinants of the immune response to infection or vaccination.
Collapse
Affiliation(s)
- Nathanael Lapidus
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
- Université Pierre et Marie Curie-Paris 6, UMR-S 707, F-75012 Paris, France
| | - Xavier de Lamballerie
- Unité des Virus Emergents, UMR-D 190, Aix-Marseille université and Institut de Recherche pour le Développement, Marseille, France
- Laboratoire de Virologie, Pôle hospitalier de Microbiologie et Maladies Infectieuses, Assistance Publique, Hôpitaux de Marseille, Marseille, France
- Ecole des Hautes Etudes en Sante Publique, Rennes, France
| | - Nicolas Salez
- Unité des Virus Emergents, UMR-D 190, Aix-Marseille université and Institut de Recherche pour le Développement, Marseille, France
| | - Michel Setbon
- CNRS – LEST, UMR 6123 Université d’Aix-Marseille, Aix en Provence, France
- Ecole des Hautes Etudes en Sante Publique, Paris, France
| | - Pascal Ferrari
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
- Université Pierre et Marie Curie-Paris 6, UMR-S 707, F-75012 Paris, France
| | - Rosemary M Delabre
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
- Université Pierre et Marie Curie-Paris 6, UMR-S 707, F-75012 Paris, France
| | - Marie-Lise Gougeon
- Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Paris, France
| | - Frédéric Vely
- Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France
- Institut National de la Santé et de la Recherche Médicale, UMR-S 631, Marseille, France
- CNRS, UMR 6102, Marseille, France
- Assistance Publique, Hôpitaux de Marseille, Hôpital de la Conception, Marseille, France
| | - Marianne Leruez-Ville
- Université Paris Descartes, Sorbonne Paris Cité, EA 36-20 Paris, France
- Laboratoire de Virologie, Hôpital Necker, AP-HP, Paris, France
| | - Laurent Andreoletti
- Unité de Virologie Médicale et Moléculaire, Centre Hospitalier Universitaire, Reims, France
- IFR 53/EA-4303 (DAT/PPCIDH), Faculté de Médecine, Reims, France
| | - Simon Cauchemez
- Medical Research Council Centre for Outbreak Analysis and Modeling, Department of Infectious Disease Epidemiology, Imperial College, London, UK
| | - Pierre-Yves Boëlle
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
- Université Pierre et Marie Curie-Paris 6, UMR-S 707, F-75012 Paris, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Unité de Santé Publique, F-75012 Paris, France
| | - Eric Vivier
- Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France
- Institut National de la Santé et de la Recherche Médicale, UMR-S 631, Marseille, France
- CNRS, UMR 6102, Marseille, France
- Assistance Publique, Hôpitaux de Marseille, Hôpital de la Conception, Marseille, France
| | - Laurent Abel
- Université Paris Descartes, Sorbonne Paris Cité, EA 36-20 Paris, France
- Laboratoire de Génétique Humaine des Maladies Infectieuses, Institut National de la Santé et de la Recherche Médicale, U 550, Paris, France
- Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA
| | - Michaël Schwarzinger
- Institut National de la Santé et de la Recherche Médicale, U 912, Marseille, France
- Université Aix Marseille, IRD, UMR-S912, Marseille, France
- Observatoire Régional de la Santé PACA, Marseille, France
| | - Michèle Legeas
- Ecole des Hautes Etudes en Sante Publique, Rennes, France
| | - Pierre Le Cann
- Ecole des Hautes Etudes en Sante Publique, Rennes, France
| | - Antoine Flahault
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
- Ecole des Hautes Etudes en Sante Publique, Rennes, France
- Ecole des Hautes Etudes en Sante Publique, Paris, France
| | - Fabrice Carrat
- Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
- Université Pierre et Marie Curie-Paris 6, UMR-S 707, F-75012 Paris, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Unité de Santé Publique, F-75012 Paris, France
| |
Collapse
|